BioTech

Pfizer Inc. (NYSE:PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved both VYNDAQEL® (tafamidis meglumine) and VYNDAMAX

PharmaCyte Biotech announces publication of U.S. patent application for cancer therapies.

DowDuPont (DWDP) said that its board has approved the separation of DowDuPont's Materials Science Division, which will become the new Dow on April 1. In connection with the separation, the DowDuPont board of directors declared a pro rata dividend of all of the outstanding shares of common stock of Dow Inc.

MARLBOROUGH, Mass., Dec. 27, 2018 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced it exercised its option to acquire th

Sun Pharma launches ready-to-infuse INFUGEM - the first and only chemotherapy product in a premixed, ready-to-infuse formulation - in the US.

Pfizer today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive op

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that it has entered into agreements to divest its Xiidra® (lifite

MARLBOROUGH, Mass., Nov. 20, 2018 /PRNewswire/ -- Boston Scientific (NYSE: BSX) today announced it has reached an agreement on the terms of a recommended offe

TARRYTOWN, N.Y. and PARIS, March 8, 2019 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the U.S. Food an

Inolex has announced it is to develop its US manufacturing facilities, with the new expansion set to replace the company’s current US production and warehouse operations. The expansion is set for completion in the second half of 2019 with a new flagship plant in Charlotte, North Carolina. David Plimpton, Inolex CEO, says, “This is a...